ClinicalTrials.govpublic full text
Study to Evaluate Safety and Effectiveness of Lenalidomide in Combination With Docetaxel and Prednisone for Patients With Castrate-Resistant Prostate Cancer
prostate cancer, castrate-resistant prostate cancer, revlimid, lenalidomide, interventional, phase3
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 813628
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.